The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...

India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...

-Economic and Political Weekly The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. The grant of a compulsory licence (CL) to Natco Pharma, a relatively small Indian pharmaceutical company, to manufacture and sell the cancer drug sorafenib (Nexavar) has been rightly hailed as a major step forward for public health and the wider availability of life saving medicines.   The German pharmaceutical company Bayer holds the patent...

-Tehelka   Victims will be able to record testimonies without being physically present in Delhi district courts Recounting the horrors of being sexually assaulted is an ordeal for victims particularly in court with the defence shooting off insensitive questions amid strangers. To ensure that victims give testimonies without fear or duress, the Delhi’s Department of Law, Justice & Legislative Affairs will soon install video conferencing facilities in courts. For the first time in...

The lesson for India after Durban is that it needs to formulate an approach that combines attention to industrialised countries’ historical responsibility for the problem with an embrace of its own responsibility to explore low carbon development trajectories. This is both ethically defensible and strategically wise. Ironically, India’s own domestic national approach of actively exploring “co-benefits” – policies that promote development while also yielding climate gains – suggests that it...